News on this topic
Corona vaccine: European Patent Office declares Moderna patent invalid: In the patent dispute over coronavirus vaccines, the European Patent Office has revoked a ...
zeit.de/gesundheit/2023-11/moderna-eu-patentamt-biontech-corona
Corona vaccine: European Patent Office declares Moderna patent invalid
Vaccine developer: EU patent office declares Moderna patent invalid: At the end of August, the US biotech company Moderna sued the Mainz company Biontech and its ...
handelsblatt.com/unternehmen/industrie/impfstoffentwickler-eu-patentamt-erklaert-moderna-patent-fuer-nichtig/29514290.html
Vaccine developer: EU patent office declares Moderna patent invalid
Similar to This
Bernd Förtsch on BioNTech: Resignation is overdue: Shareholder Bernd Förtsch sharply criticizes the events at the Corona superstar.
deraktionaer.de/artikel/aktien/bernd-foertsch-ueber-biontech-ruecktritt-ist-ueberfaellig-20409989.html
Bernd Förtsch on BioNTech: Resignation is overdue
Dispute over spin-off: Are the former bosses hollowing out BioNTech?: Uğur Şahin and Özlem Türeci plan to leave BioNTech and found a new company in 2027 ...
boerse-online.de/nachrichten/aktien/streit-um-abspaltung-hoehlen-die-ex-chefs-biontech-aus-20409499.html
Dispute over spin-off: Are the former bosses hollowing out BioNTech?
Moderna stock knows no bounds - | what's going on with BioNTech?: The stock has roughly tripled since the positive data was released.
deraktionaer.de/artikel/pharma-biotech/moderna-aktie-kennt-kein-halten-mehr-was-ist-mit-biontech-los-20409301.html
Moderna stock knows no bounds - | what's going on with BioNTech?
mRNA cancer vaccine: After soaring high, setback for Mainz-based BioNTech: After strong test data from its US competitor Moderna, BioNTech's stock price shot ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/mrna-krebsimpfstoff-nach-hoehenflug-rueckschlag-fuer-biontech-6171151
mRNA cancer vaccine: After soaring high, setback for Mainz-based BioNTech
BioNTech: mRNA Setback with Signal Effect - | Moderna's Fantasy Fizzles Out: Moderna Excites, BioNTech with Setback.
deraktionaer.de/artikel/pharma-biotech/biontech-mrna-rueckschlag-mit-signalwirkung-moderna-fantasie-verpufft-20407749.html
BioNTech: mRNA Setback with Signal Effect - | Moderna's Fantasy ...
Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more
statnews.com/pharmalot/2026/08/13/california-insulin-sales-moderna-patent-battle/
Pharmalittle: We’re reading about California insulin sales ...
Panasonic did what Apple, Sony and Nikon couldn’t: overturn a Red Raw video patent
dpreview.com/news/panasonic-did-what-apple-sony-and-nikon-couldnt-overturn-a-red-raw-video-patent/
Panasonic did what Apple, Sony and Nikon couldn’t: overturn a Red Raw ...
FDA warns more telehealth firms about compounded GLP-1s: Today's biotech news covers Moderna to pay major settlement in Roivant patent case ...
statnews.com/2026/03/04/biotech-news-fda-warns-telehealth-about-glp-1-compounding/
FDA warns more telehealth firms about compounded GLP-1s
Moderna to pay Roivant up to $2.25 billion to settle patent lawsuit behind mRNA vaccines
statnews.com/2026/03/03/moderna-settles-covid-vaccine-suit-roivant/
Moderna to pay Roivant up to $2.25 billion to settle patent lawsuit behind ...
Moderna’s stock rallies as deal over a patent dispute clears vaccine pipeline: Resolution will provide ‘certainty’ for Moderna’s portfolio, company says
marketwatch.com/story/modernas-stock-rallies-more-than-10-as-deal-over-a-patent-dispute-clears-vaccine-pipeline-d34e6793
Moderna’s stock rallies as deal over a patent dispute clears vaccine ...
BioNTech sues Moderna - | the details: BioNTech sues Moderna for patent infringement; shares of both companies remain stable.
deraktionaer.de/artikel/pharma-biotech/biontech-verklagt-moderna-die-details-20395822.html
BioNTech sues Moderna - | the details
Bayer sues COVID vaccine makers over mRNA technology: Bayer's Monsanto sued COVID-19 vaccine makers Pfizer , BioNTech and Moderna in Delaware federal court on ...
reuters.com/legal/litigation/bayer-sues-covid-vaccine-makers-over-mrna-technology-2026-01-06/
Bayer sues COVID vaccine makers over mRNA technology
Patents: Corona vaccines - | Bayer sues BioNTech, Pfizer and Moderna: Bayer accuses several manufacturers of copying an old technology to produce mRNA vaccines ...
handelsblatt.com/unternehmen/industrie/patente-corona-impfstoffe-bayer-verklagt-biontech-pfizer-und-moderna/100189227.html
Patents: Corona vaccines - | Bayer sues BioNTech, Pfizer and Moderna
Biotech: BioNTech finalizes CureVac acquisition: The merger of the two vaccine developers is complete. BioNTech is acquiring its competitor CureVac - | and thus ...
handelsblatt.com/unternehmen/industrie/biotech-biontech-macht-uebernahme-von-curevac-perfekt/100185010.html
Biotech: BioNTech finalizes CureVac acquisition
Curevac and Biontech end dispute: Agreement thanks to takeover: Curevac and its partner GSK will receive a total of 740 million euros for the rights to Covid-19 ...
swp.de/lokales/tuebingen/curevac-und-biontech-beenden-streit-einigung-dank-uebernahme-78234691.html
Curevac and Biontech end dispute: Agreement thanks to takeover